KSA-Based Thakaa Med Raises Seed Investment through Falak Angels

This capital will be used to enhance Thakaa Med’s AI models and support the launch its flagship products.

Thakaa Med, an emerging leader in Saudi Arabia's healthtech industry, has recently raised seed investment through the Falak Angels syndicate. Founded in 2022 by Alwaleed Albadr, Thakaa Med specializes in AI-driven healthcare solutions, focusing on transforming patient care with advanced predictive, preventive, and personalized technologies. This funding represents a pivotal moment for the company as it seeks to enhance its AI capabilities and launch its flagship products.

Investment to Advance AI-Driven Healthcare

The seed funding secured by Thakaa Med will be crucial in accelerating the development and refinement of its AI models. These models are designed to provide cutting-edge diagnostic and treatment solutions, positioning Thakaa Med at the forefront of healthcare innovation. The investment will also support the market introduction of Thakaa Med's flagship products, Dental IQ and Chest IQ, which aim to revolutionize healthcare delivery in Saudi Arabia and beyond.

Driving the Future of HealthTech in Saudi Arabia

Thakaa Med's plans to utilize this investment extend beyond mere product development. The company is committed to establishing a strong AI infrastructure in Riyadh, which aligns with the broader goals of Saudi Arabia's Vision 2030 initiative. By fostering local talent and cultivating a new generation of AI experts, Thakaa Med is contributing to the Kingdom's ambition of becoming a global leader in health tech innovation.

Falak Angels’ Support and Vision

Falak Angels, known for its strategic support of innovative startups across the MENA region, played a significant role in Thakaa Med's recent funding round. The syndicate’s involvement highlights its dedication to empowering tech-driven companies that are poised to make a significant impact. Under the leadership of Adwa Aldakheel, Falak Angels continues to provide both financial backing and strategic resources to ensure the success of startups like Thakaa Med.

Thakaa Med's recent seed funding marks a significant milestone in its mission to transform healthcare through AI. With the support of Falak Angels, the company is well-positioned to advance its AI technologies, launch its innovative products, and contribute to the realization of Saudi Arabia's Vision 2030. As Thakaa Med continues to push the boundaries of AI-driven healthcare, it is playing a vital role in shaping the future of health tech in the Kingdom.